CEFTRIAXONE SODIUM 2 g - search results

Australia - English - Department of Health (Therapeutic Goods Administration)

ceftriaxone kabi ceftriaxone (as sodium) 0.5 g powder for injection vial

fresenius kabi australia pty ltd - ceftriaxone sodium, quantity: 596.5 mg (equivalent: ceftriaxone, qty 500 mg) - injection, powder for - excipient ingredients: - ceftriaxone is indicated for the treatment of the following infections when caused by susceptible aerobic organisms.,lower respiratory tract infections caused by s. pneumoniae, streptococcus species (excluding enterococci), methicillin sensitive s. aureus, h. influenzae, h. parainfluenzae, klebsiella species (including k. pneumoniae), e. coli, e. aerogenes, proteus mirabilis and serratia marcescens.,skin and skin structure infections caused by methicillin sensitive s. aureus, methicillin sensitive s. epidermidis, streptococcus group b, streptococcus group g, streptococcus pyogenes, streptococcus viridans, streptococcus species (excluding enterococci), peptostreptococcus species, e. coli, e. cloacae, klebsiella species (including k. pneumoniae, k. oxytoca), proteus mirabilis, morganella morganii, serratia marcescens.,urinary tract infections (complicated and uncomplicated) caused by e. coli, proteus mirabilis, proteus vulgaris, m. morganii and klebsiella species (including k. pneumoniae).,uncomplicated gonorrh

Australia - English - Department of Health (Therapeutic Goods Administration)

ceftriaxone kabi ceftriaxone (as sodium) 1 g powder for injection vial

fresenius kabi australia pty ltd - ceftriaxone sodium, quantity: 1193 mg (equivalent: ceftriaxone, qty 1000 mg) - injection, powder for - excipient ingredients: - ceftriaxone is indicated for the treatment of the following infections when caused by susceptible aerobic organisms.,lower respiratory tract infections caused by s. pneumoniae, streptococcus species (excluding enterococci), methicillin sensitive s. aureus, h. influenzae, h. parainfluenzae, klebsiella species (including k. pneumoniae), e. coli, e. aerogenes, proteus mirabilis and serratia marcescens.,skin and skin structure infections caused by methicillin sensitive s. aureus, methicillin sensitive s. epidermidis, streptococcus group b, streptococcus group g, streptococcus pyogenes, streptococcus viridans, streptococcus species (excluding enterococci), peptostreptococcus species, e. coli, e. cloacae, klebsiella species (including k. pneumoniae, k. oxytoca), proteus mirabilis, morganella morganii, serratia marcescens.,urinary tract infections (complicated and uncomplicated) caused by e. coli, proteus mirabilis, proteus vulgaris, m. morganii and klebsiella species (including k. pneumoniae).,uncomplicated gonorrh